Inotuzumab Ozogamicin

ATC L01FB01 · 11 markets · 13 records

Inotuzumab Ozogamicin 11 markets · 13 records Forms

AU 3 records · 2 strengths

1 mginjectionBesponsa+1BESPONSA inotuzumab ozogamicin 1 mg powder for injection vial also in GB·CN·ES +1 unknown

Records without a stated strength · 1 Besponsa

US 1 records · 1 strengths

0.25 mginjectionBesponsa

GB 1 records · 1 strengths

1 mginjectionBesponsa 1mg powder for concentrate for solution for infusion vials also in AU·CN·ES +1

CA 1 records · 1 strengths

0.9 mgpowderBesponsa

SG 1 records · 1 strengths

1 mg/vialpowderBESPONSA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/VIAL

CN 1 records · 1 strengths

1 mginjection贝博萨奥加伊妥珠单抗 also in AU·GB·ES +1

ES 1 records · 1 strengths

1 mginjectionBesponsa also in AU·GB·CN +1

MX 1 records · 1 strengths

Records without a stated strength · 1 Besponsa

TW 1 records · 1 strengths

1 mginjectionBESPONSA 1 mg Powder for Concentrate for Solution for infusion+1沛斯博凍晶注射劑1毫克 also in AU·GB·CN +1

HK 1 records · 1 strengths

Records without a stated strength · 1 BESPONSA 1 mg Powder for Concentrate for Solution for infusion

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Besponsa

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.